Literature DB >> 4636892

Clear-cell adenocarcinoma of the genital tract in young females. Registry report.

A L Herbst, R J Kurman, R E Scully, D C Poskanzer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4636892     DOI: 10.1056/NEJM197212212872501

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  25 in total

Review 1.  Complications of systemic oral contraceptive therapy: Neoplasm--breast, uterus, cervix and vagina.

Authors:  M A Sperling
Journal:  West J Med       Date:  1975-01

2.  Transplacental carcinogenesis.

Authors:  P N Magee
Journal:  Proc R Soc Med       Date:  1975-10

Review 3.  The development of cervical and vaginal adenosis as a result of diethylstilbestrol exposure in utero.

Authors:  Monica M Laronda; Kenji Unno; Lindsey M Butler; Takeshi Kurita
Journal:  Differentiation       Date:  2012-06-06       Impact factor: 3.880

4.  Vaginal adenosis.

Authors:  A L Herbst
Journal:  Calif Med       Date:  1973-07

5.  Sexual morbidity in very long term survivors of vaginal and cervical cancer: a comparison to national norms.

Authors:  Stacy Tessler Lindau; Natalia Gavrilova; Diane Anderson
Journal:  Gynecol Oncol       Date:  2007-06-20       Impact factor: 5.482

Review 6.  Environmental teratogens.

Authors:  R L Brent; D A Beckman
Journal:  Bull N Y Acad Med       Date:  1990 Mar-Apr

7.  Treatment of endocrine diseases.

Authors:  W M Hague
Journal:  Br Med J (Clin Res Ed)       Date:  1987-01-31

8.  Persistent inverse maternal effect on corticosterone production in vitro.

Authors:  P R Wood; J G Shire
Journal:  Experientia       Date:  1984-09-15

9.  Metabolic activation of diethylstilbestrol and aminostilbene-derivatives.

Authors:  H G Neumann; M Metzler; W Töpner
Journal:  Arch Toxicol       Date:  1977-12-30       Impact factor: 5.153

10.  Neonatal tumours: Glasgow 1955-86.

Authors:  C F Davis; R Carachi; D G Young
Journal:  Arch Dis Child       Date:  1988-09       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.